Meeting
2013 Gastrointestinal Cancers Symposium
Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma.
Authors
Elizabeth Won
Memorial Sloan-Kettering Cancer Center
Elizabeth Won , David Ilson , David Kelsen , Vivian Strong , Heiko Schöder , Yelena Janjigian , Manish Shah , Daniel Coit , Murray Brennan , Marinela Capanu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT00737438
Citation
J Clin Oncol 31, 2013 (suppl 4; abstr94)
DOI
10.1200/jco.2013.31.4_suppl.94
Abstract #
94
Poster Bd #
B38
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma.
First Author: Geoffrey Yuyat Ku
Poster
2015 Gastrointestinal Cancers Symposium
Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma without overexpression of HER2 receptors.
First Author: Sebastian Ochenduszko
Poster
2023 ASCO Annual Meeting
Perioperative immunochemotherapy (mDCF + avelumab) in locally advanced gastro-esophageal adenocarcinoma: A phase II trial.
First Author: Thierry Alcindor
Poster
2021 ASCO Annual Meeting
Phase II trial of perioperative chemotherapy + avelumab in locally advanced gastroesophageal adenocarcinoma: Preliminary results.
First Author: Thierry Alcindor